# H1-10

## Overview
H1-10 is a gene that encodes the H1.10 linker histone protein, a member of the histone H1 family involved in chromatin structure and function. The H1.10 protein plays a crucial role in the organization of chromatin by binding to the nucleosome, thereby influencing gene expression and DNA accessibility. Unlike other histone proteins, H1.10 is associated with specific cellular states, such as differentiation and low proliferative activity, which distinguishes it from other H1 variants. The expression of H1.10 is notably variable across different tissue types and pathological conditions, making it a potential biomarker for tumor differentiation and progression in cancers such as ovarian and breast cancer (Kostova2005Immunohistochemical; Medrzycki2012Profiling).

## Clinical Significance
Alterations in the expression of the H1-10 gene, also known as H1.0, have been implicated in various cancers, including ovarian and breast cancer. In ovarian cancer, H1.0 expression is significantly reduced in malignant adenocarcinomas compared to benign adenomas. This reduction is associated with the progression from benign to malignant tumors, suggesting a potential role for H1.0 in ovarian carcinogenesis (Medrzycki2012Profiling). The differential expression of H1.0 and other H1 variants can serve as biomarkers for distinguishing between benign and malignant ovarian tumors, with hierarchical clustering analysis achieving high accuracy in segregating these tumor types (Medrzycki2012Profiling).

In breast cancer, H1.0 expression is observed in both benign and malignant tissues, with a higher presence in more differentiated tumors. This expression pattern challenges the traditional view that H1.0 is associated solely with terminal differentiation. Instead, it may indicate a state of low proliferative activity, as H1.0 is present in cells during a prolonged intermitotic period (Kostova2005Immunohistochemical). The expression of H1.0 in breast carcinoma is variable, with higher levels in more differentiated tumors and lower levels in poorly differentiated ones, suggesting its potential as a marker for tumor differentiation (Kostova2005Immunohistochemical).


## References


[1. (Kostova2005Immunohistochemical) Nora N. Kostova, Ljuba N. Srebreva, Angel D. Milev, Olga G. Bogdanova, Ingemar Rundquist, Herbert H. Lindner, and Dimiter V. Markov. Immunohistochemical demonstration of histone h10 in human breast carcinoma. Histochemistry and Cell Biology, 124(5):435â€“443, November 2005. URL: http://dx.doi.org/10.1007/s00418-005-0052-6, doi:10.1007/s00418-005-0052-6. This article has 23 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00418-005-0052-6)

[2. (Medrzycki2012Profiling) Magdalena Medrzycki. Profiling of linker histone variants in ovarian cancer. Frontiers in Bioscience, 17(1):396, 2012. URL: http://dx.doi.org/10.2741/3934, doi:10.2741/3934. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.2741/3934)